Keywords: chugai, interim, net, income, rises, pharmaceutical, japan
Chugai interim net income rises 8.7%
Article | 30 November 2000
Chugai Pharmaceutical of Japan has reported an 8.7% rise in net incomefor the six-month period ended September 30 to 10.31 billion yen ($93.2 million) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
